ClinConnect ClinConnect Logo
Search / Trial NCT06489327

Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery

Launched by AL-AZHAR UNIVERSITY · Jun 28, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Preoperative Anxiety General Anesthesia Major Surgery Oral Melatonin Placebo Premedication

ClinConnect Summary

This clinical trial is studying how effective two different doses of oral melatonin are at reducing anxiety in children before they undergo surgery. Many kids feel anxious about surgery because they are unsure of what to expect, which can make the experience more stressful for them. This study aims to see if melatonin, a natural sleep aid, can help calm children down before their procedures, as an alternative to commonly used medications that might have unwanted side effects.

Children aged 4 to 14 years who are scheduled for elective surgeries may be eligible to participate in this trial. To join, they should be generally healthy (classified as ASA physical status I or II) and not have any significant allergies or gastrointestinal disorders. If they take part in the study, participants will receive either a low or high dose of melatonin before their surgery and will be monitored to see how it affects their anxiety levels. This trial is currently looking for volunteers and aims to find a safer and more effective way to help kids feel more relaxed during what can be a scary time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients of either sex
  • age from 4 to 14 years
  • Patients with American society Anesthesiologist physical status I and II
  • Patients undergoing elective surgeries
  • Exclusion Criteria:
  • ASA more than III
  • Drug allergy.
  • Gastrointestinal disorders.

About Al Azhar University

Al-Azhar University, a prestigious institution in Egypt, is dedicated to advancing medical research and education through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university aims to contribute to the development of innovative therapies and healthcare solutions. By fostering collaboration among researchers, healthcare professionals, and academic experts, Al-Azhar University positions itself as a leading sponsor in clinical research, committed to improving patient outcomes and enhancing the understanding of various medical conditions.

Locations

Cairo, , Egypt

Madīnat Bābil, Babel, Iraq

Patients applied

0 patients applied

Trial Officials

Neveen Kohaf, ph.d

Principal Investigator

Al-Azhar University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported